HBM vs. UTHR
HBM (Hudbay Minerals Inc.) and UTHR (United Therapeutics Corporation) are both stocks. HBM operates in Copper (Basic Materials), while UTHR operates in Biotechnology (Healthcare). Over the past 10 years, HBM returned 18.60%/yr vs 17.20%/yr for UTHR. At a 0.20 correlation, their price movements are largely independent.
Performance
HBM vs. UTHR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HBM achieves a 31.58% return, which is significantly higher than UTHR's 11.79% return. Over the past 10 years, HBM has outperformed UTHR with an annualized return of 18.60%, while UTHR has yielded a comparatively lower 17.20% annualized return.
HBM
- 1D
- 1.75%
- 1M
- 4.36%
- YTD
- 31.58%
- 6M
- 50.45%
- 1Y
- 171.66%
- 3Y*
- 77.46%
- 5Y*
- 30.42%
- 10Y*
- 18.60%
UTHR
- 1D
- -0.94%
- 1M
- -3.58%
- YTD
- 11.79%
- 6M
- 13.59%
- 1Y
- 67.18%
- 3Y*
- 33.59%
- 5Y*
- 25.53%
- 10Y*
- 17.20%
HBM vs. UTHR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HBM Hudbay Minerals Inc. | 31.58% | 145.46% | 47.03% | 9.24% | -29.87% | 3.82% | 69.50% | -11.77% | -46.20% | 54.77% |
UTHR United Therapeutics Corporation | 11.79% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 72.33% | -19.12% | -26.39% | 3.15% |
Correlation
The correlation between HBM and UTHR is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Feb 13, 2009 | 0.20 |
Fundamentals
HBM:
$10.41B
UTHR:
$25.71B
HBM:
$1.65
UTHR:
$27.00
HBM:
15.79
UTHR:
20.17
HBM:
0.11
UTHR:
0.66
HBM:
4.39
UTHR:
8.19
HBM:
2.94
UTHR:
4.36
HBM:
$2.37B
UTHR:
$3.17B
HBM:
$828.54M
UTHR:
$2.74B
HBM:
$1.54B
UTHR:
$1.75B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HBM vs. UTHR — Risk / Return Rank
HBM
UTHR
HBM vs. UTHR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Hudbay Minerals Inc. (HBM) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HBM | UTHR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.60 | ||
| Sortino ratioReturn per unit of downside risk | +0.33 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.37 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 4.78 | 4.13 | +0.65 |
| Martin ratioReturn relative to average drawdown | 15.13 | 10.54 | +4.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HBM | UTHR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.96 | 1.36 | +1.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.55 | 0.73 | -0.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.32 | 0.49 | -0.17 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.20 | 0.38 | -0.18 |
Drawdowns
HBM vs. UTHR - Drawdown Comparison
The maximum HBM drawdown since its inception was -92.21%, roughly equal to the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for HBM and UTHR.
Loading charts...
Drawdown Indicators
| HBM | UTHR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.21% | -93.18% | +0.97% |
Max Drawdown (1Y)Largest decline over 1 year | -36.16% | -16.35% | -19.81% |
Max Drawdown (3Y)Largest decline over 3 years | -41.11% | -33.00% | -8.11% |
Max Drawdown (5Y)Largest decline over 5 years | -63.33% | -33.00% | -30.33% |
Max Drawdown (10Y)Largest decline over 10 years | -86.34% | -55.56% | -30.78% |
Current DrawdownCurrent decline from peak | -18.07% | -8.73% | -9.34% |
Average DrawdownAverage peak-to-trough decline | -52.50% | -35.31% | -17.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.40% | 6.39% | +5.01% |
Volatility
HBM vs. UTHR - Volatility Comparison
Hudbay Minerals Inc. (HBM) has a higher volatility of 25.29% compared to United Therapeutics Corporation (UTHR) at 5.15%. This indicates that HBM's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HBM | UTHR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.29% | 5.15% | +20.14% |
Volatility (6M)Calculated over the trailing 6-month period | 46.90% | 26.01% | +20.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 58.55% | 49.84% | +8.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 55.36% | 35.13% | +20.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 58.79% | 35.07% | +23.72% |
Dividends
HBM vs. UTHR - Dividend Comparison
HBM's dividend yield for the trailing twelve months is around 0.05%, while UTHR has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HBM Hudbay Minerals Inc. | 0.05% | 0.07% | 0.17% | 0.31% | 0.32% | 0.22% | 0.21% | 0.36% | 0.38% | 0.23% | 0.35% | 0.52% |
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
HBM vs. UTHR - Financials Comparison
This section allows you to compare key financial metrics between Hudbay Minerals Inc. and United Therapeutics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HBM vs. UTHR - Profitability Comparison
HBM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hudbay Minerals Inc. reported a gross profit of 340.81M and revenue of 745.43M. Therefore, the gross margin over that period was 45.7%.
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.
HBM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hudbay Minerals Inc. reported an operating income of 297.62M and revenue of 745.43M, resulting in an operating margin of 39.9%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.
HBM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hudbay Minerals Inc. reported a net income of 187.76M and revenue of 745.43M, resulting in a net margin of 25.2%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.
Frequently Asked Questions
HBM and UTHR have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HBM has higher volatility (25.29%) compared to UTHR (5.15%). In terms of maximum drawdown, HBM dropped -92.21% vs UTHR's -93.18%.
HBM currently has the higher Sharpe Ratio (2.96 vs 1.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HBM and UTHR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer